Glycated Albumin, a Novel Biomarker for Short-Term Functional Outcomes in Acute Ischemic Stroke

Background: There is growing interest in the use of new biomarkers such as glycated albumin (GA), but data are limited in acute ischemic stroke. We explored the impact of GA on short-term functional outcomes as measured using the modified Rankin Scale (mRS) at 3 months compared to glycated hemoglobi...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Brain Sci
Main Authors: Kim, Yerim, Lee, Sang-Hwa, Kang, Min Kyoung, Kim, Tae Jung, Jeong, Han-Yeong, Lee, Eung-Joon, Bae, Jeonghoon, Jeon, Kipyoung, Nam, Ki-Woong, Yoon, Byung-Woo
Formato: Artigo
Idioma:Inglês
Publicado: MDPI 2021
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC8000654/
https://ncbi.nlm.nih.gov/pubmed/33800924
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/brainsci11030337
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares